AHA 2025 Conference Recap: 4 Late-Breaking Trials to Know

The American Heart Association’s Scientific Sessions 2025, in New Orleans, Louisiana, were – as always - a hotbed for critical cardiology news. Everything from dyslipidemia to atherosclerotic cardiovascular disease (ASCVD) saw exciting new data, with plenty of critical trial results announced and upcoming therapies showcased.